169 related articles for article (PubMed ID: 9052405)
1. Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
el-Mahdani N; Vaillant JC; Guiguet M; Prévot S; Bertrand V; Bernard C; Parc R; Béréziat G; Hermelin B
Br J Cancer; 1997; 75(4):528-36. PubMed ID: 9052405
[TBL] [Abstract][Full Text] [Related]
2. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
[TBL] [Abstract][Full Text] [Related]
3. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.
Morrin M; Kelly M; Barrett N; Delaney P
Gut; 1994 Nov; 35(11):1627-31. PubMed ID: 7828987
[TBL] [Abstract][Full Text] [Related]
4. Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer.
Pan ZZ; Wan DS; Chen G; Li LR; Lu ZH; Huang BJ
World J Gastroenterol; 2004 Dec; 10(24):3688-90. PubMed ID: 15534934
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in colorectal cancer.
Rodrigues NR; Rowan A; Smith ME; Kerr IB; Bodmer WF; Gannon JV; Lane DP
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7555-9. PubMed ID: 1699228
[TBL] [Abstract][Full Text] [Related]
6. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
7. [p53 gene point mutation in human colorectal carcinoma].
Xu W; Yang D; Wan Y
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967
[TBL] [Abstract][Full Text] [Related]
8. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
9. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
10. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas.
Itoi T; Watanabe H; Yoshida M; Ajioka Y; Nishikura K; Saito T
Pathol Int; 1997 Aug; 47(8):525-30. PubMed ID: 9293532
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
[TBL] [Abstract][Full Text] [Related]
12. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
13. [Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].
Wei JB; Chen LS; Gao F
Ai Zheng; 2005 Feb; 24(2):141-4. PubMed ID: 15694021
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Akervall J; Wennerberg J
Br J Cancer; 1998 Oct; 78(8):1084-90. PubMed ID: 9792155
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of oncogenesis in colon versus rectal cancer.
Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study on p53 gene mutation in primary human Dukes C colon cancer with that in matched lymph node metastasis].
Zhang J; Caplin S; Benhattar J
Zhonghua Bing Li Xue Za Zhi; 1997 Apr; 26(2):85-8. PubMed ID: 10072877
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.
Ward R; Meagher A; Tomlinson I; O'Connor T; Norrie M; Wu R; Hawkins N
Gut; 2001 Jun; 48(6):821-9. PubMed ID: 11358903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
